<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Thiazides first for hypertension?</title>
	<atom:link href="http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/</link>
	<description>An NHS Prescribing Advisers' Blog</description>
	<pubDate>Fri, 05 Sep 2008 22:39:42 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
		<item>
		<title>By: Matthew Robinson</title>
		<link>http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/#comment-2421</link>
		<dc:creator>Matthew Robinson</dc:creator>
		<pubDate>Wed, 06 Feb 2008 09:59:13 +0000</pubDate>
		<guid isPermaLink="false">http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/#comment-2421</guid>
		<description>Minto,

This analysis was conducted on the ALLHAT study which used chlorthalidone as the thiazide drug for the study. This choice is based on market share usage in America.

In Britain, bendroflumethiazide is the most popular thiazide and of course it was studied in ASCOT. Of course ASCOT wasn't as favourable in terms of outcomes but there are limitations to the study when looking at the doses of thiazide and beta blocker used. Additionally, indapamide has been studied in the PROGRESS study. 

So, should you continue to use what you know and are comfortable with or changed to the thiazide used in ALLHAT. There is no clear evidence that there are differences between these drugs so continuing with bendroflumethiazide would seem a rational choice.</description>
		<content:encoded><![CDATA[<p>Minto,</p>
<p>This analysis was conducted on the ALLHAT study which used chlorthalidone as the thiazide drug for the study. This choice is based on market share usage in America.</p>
<p>In Britain, bendroflumethiazide is the most popular thiazide and of course it was studied in ASCOT. Of course ASCOT wasn&#8217;t as favourable in terms of outcomes but there are limitations to the study when looking at the doses of thiazide and beta blocker used. Additionally, indapamide has been studied in the PROGRESS study. </p>
<p>So, should you continue to use what you know and are comfortable with or changed to the thiazide used in ALLHAT. There is no clear evidence that there are differences between these drugs so continuing with bendroflumethiazide would seem a rational choice.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: minto</title>
		<link>http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/#comment-2420</link>
		<dc:creator>minto</dc:creator>
		<pubDate>Tue, 05 Feb 2008 23:53:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.prescriber.org.uk/2008/01/30/thiazides-first-for-hypertension/#comment-2420</guid>
		<description>the subgroup analysis supports the use of chlorthalidone. however is this a class effect and is bendroflumethiazide the same? are all thiazide diuretics the same? where is the evidence for bendroflumethiazide?</description>
		<content:encoded><![CDATA[<p>the subgroup analysis supports the use of chlorthalidone. however is this a class effect and is bendroflumethiazide the same? are all thiazide diuretics the same? where is the evidence for bendroflumethiazide?</p>
]]></content:encoded>
	</item>
</channel>
</rss>
